Table 1 Relationship between the participants’ characteristics and their UDI score and IIQ-7 score
From: An evaluation of lower urinary tract symptoms in diabetic patients: a cross-sectional study
Characteristic | Frequency (%) N = 378 | UDI-6 score Median [Q1–Q3] | Mean Rank (UDI-6 score) | P-value* | IIQ-7 score Median [Q1–Q3] | Mean Rank (IIQ-7 score) | P-value* |
|---|---|---|---|---|---|---|---|
Age category | 0.003a | < 0.001a | |||||
Under 38 | 62 (16.4) | 3 (2–6) | 150.07 | 0 (0–3) | 130.19 | ||
38–47 | 34 (9.0) | 5 (4–6.3) | 185.13 | 3 (0–4.5) | 146.24 | ||
48–57 | 93 (24.6) | 6 (1.5–8) | 185.97 | 4 (0–9) | 183.01 | ||
58–67 | 113 (29.9) | 6 (2–9) | 191.62 | 7 (0–10.5) | 202.59 | ||
68 and older | 76 (20.1) | 6 (3–11) | 224.78 | 9 (5–11) | 245.72 | ||
Sex | 0.007b | < 0.001b | |||||
Male | 192 (50.8) | 5 (2–7) | 174.69 | 3 (0–8) | 169.36 | ||
Female | 186 (49.2) | 6 (2–10) | 204.79 | 7 (0–11) | 210.29 | ||
Smoking Status | 0.91b | 0.072 b | |||||
Smoker | 218 (57.7) | 6 (2–80 | 188.76 | 4 (0–8) | 177.88 | ||
Non-smoker | 160 (42.3) | 5 (2–9) | 190.04 | 7 (0–10.5) | 198.03 | ||
BMI | 0.010a | < 0.001a | |||||
Normal | 74 (19.6) | 4 (2–6) | 158.34 | 0 (0–6.3) | 138.99 | ||
Overweight | 187 (49.5) | 6 (2–8) | 190.78 | 4 (0–9) | 180.52 | ||
Obese | 117 (31.0) | 6 (2–10) | 207.17 | 8 (3–12) | 235.80 | ||
Marital Status | 0.008b | 0.022b | |||||
Single | 145 (38.4) | 6.0 (3.0–11.0) | 208.27 | 7.0 (0.0–11.0) | 205.55 | ||
Married | 233 (61.6) | 5.0 (2.0–7.5) | 177.82 | 4.0 (0.0–9.0) | 179.51 | ||
Residency | 0.037a | 0.027a | |||||
City | 168 (44.4) | 4 (2–7) | 174.47 | 3 (0–8) | 172.92 | ||
Village | 174 (46.0) | 6 (2–9.25) | 198.43 | 6 (0–10) | 202.68 | ||
Refugee camp | 36 (9.5) | 6 (3–12) | 216.49 | 7 (0–9) | 203.19 | ||
Educational level | 0.043b | < 0.001b | |||||
School | 219 (57.9) | 6.0 (2.0–10.0) | 199.15 | 7.0 (1.0–11.0) | 212.36 | ||
University | 159 (42.1) | 5.0 (2.0–7.0) | 176.20 | 2.0 (0.0–8.0) | 158.01 | ||
Job | 0.013b | < 0.001b | |||||
Unemployed | 248 (65.6) | 6.0 (2.0–9.8) | 199.51 | 7.0 (0.0–11.0) | 207.5 | ||
Employed | 130 (34.4) | 4.0 (2.0–7.0) | 170.41 | 2.0 (0.0–7.0) | 155.16 | ||
Income | 0.017a | < 0.001a | |||||
Less than 2000 NIS | 171 (45.2) | 5 (2–8) | 185.84 | 7 (0–11) | 210.67 | ||
2000–5000 NIS | 139 (36.8) | 6 (3–9) | 208.70 | 5.5 (0–9) | 188.24 | ||
5000–10,000 NIS | 58 (15.3) | 4 (3–6.25) | 163.16 | 1 (0–4.25) | 142.58 | ||
More than 10,000 | 10 (2.6) | 3 (0–9) | 137.90 | 0.5 (0–4) | 117.20 | ||
Type of insurance | < 0.001a | < 0.001a | |||||
None | 50 (13.2) | 8 (4.75–12) | 250.30 | 9.5 (2.75–12) | 240.74 | ||
Governmental | 294 (77.8) | 5 (2–8) | 183.59 | 5 (0–9) | 188.44 | ||
Private | 34 (9.0) | 4 (2–5.25) | 151.19 | 0 (0–3.25) | 123.35 | ||
Place of Birth | 0.859b | 0.604b | |||||
In Palestine | 350 (92.6) | 5 (2–8) | 189.78 | 5 (0–10) | 190.31 | ||
Outside Palestine | 28 (7.4) | 6 (2–7) | 185.98 | 2.5 (0–10) | 179.36 | ||
Type of DM | 0.009b | < 0.001b | |||||
Type 1 DM | 73 (19.3) | 4 (2–6) | 159.60 | 0 (0–6) | 134.01 | ||
Type 2 DM | 305 (80.7) | 6 (2–8.75) | 196.66 | 6 (0–10) | 202.78 | ||
Duration of DM (years) | 0.069a | 0.271a | |||||
1–3 | 42 (11.1) | 3.5 (2.0–7.0) | 153.65 | 3.5 (0.0–11.0) | 192.70 | ||
4–5 | 42 (11.1) | 4.0 (2.8–8.3) | 186.48 | 3.0 (0.0–8.3) | 164.24 | ||
> 5 | 294 (77.8) | 6.0 (2.0–9.0) | 195.05 | 5.0 (0.0–9.3) | 192.65 | ||
Treatment type | 0.000a | 0.009a | |||||
Lifestyle modification | 14 (3.7) | 2.5 (0–4) | 106.21 | 1 (0–14) | 167.07 | ||
Monotherapy | 214 (56.6) | 5 (2–8) | 180.12 | 4 (0–9) | 176.43 | ||
Combined therapy | 150 (39.7) | 6 (3–10) | 210.65 | 7 (1–11) | 210.23 | ||
Insulin use | 0.043b | 0.649b | |||||
Yes | 201 (53.2) | 6 (3–9.75) | 200.14 | 4 (0–9) | 187.13 | ||
No | 177 (46.8) | 4 (2–8) | 177.42 | 6 (0–10) | 192.19 | ||
Co-morbidities | < 0.001b | < 0.001b | |||||
Yes | 247 (65.3) | 6 (3–10) | 210.20 | 7 (1–10) | 209.46 | ||
No | 131 (34.7) | 4 (2–6) | 150.47 | 1 (0–8) | 151.87 | ||
Total number of co-morbidities | < 0.001a | < 0.001a | |||||
0 | 131 (34.7) | 4.0 (2.0–6.0) | 150.47 | 1.0 (0.0–8.0) | 151.87 | ||
1 | 194 (51.3) | 6.0 (3.0–10.0) | 212.51 | 7.0 (1.0–10.0) | 203.38 | ||
≥ 2 | 53 (14.0) | 6.0 (2.0–10.5) | 201.76 | 8.0 (2.5–13.5) | 231.72 | ||
Regular Exercise | < 0.001b | < 0.001b | |||||
Yes | 108 (28.6) | 3 (0–6) | 146.69 | 0 (0–4) | 127.50 | ||
No | 270 (71.4) | 6 (3–9) | 206.62 | 7 (1–11) | 214.30 | ||
Alcohol intake | 0.002b | 0.041b | |||||
Yes | 11 (2.9) | 0 (0–3) | 90.95 | 0 (0–9) | 124.18 | ||
No | 367 (97.1) | 6 (2–8) | 192.45 | 5 (0–10) | 191.46 | ||